Community-wide awareness that antiretroviral therapies (ART) provides protection against HIV has the potential to increase perceived safety and thereby increase condomless anal sex among men who have sex with men (MSM). Furthermore, reductions in condom use can increase exposure to sexually transmitted infections, which in turn can reduce the protective effects of ART on HIV transmission. The current study extends previous community-based behavioral surveillance research on beliefs regarding use of ART for HIV prevention and sexual practices among MSM. Anonymous cross-sectional community surveys were collected from 1831 men at the same gay pride event in Atlanta, GA four times over nearly two decades; 1997, 2005–2006 (the 2006 survey over-sampled African-Americans to diversify the study), and 2015. Results indicate clear and consistent trends of increasing beliefs that HIV treatments reduce HIV transmission risks, reflecting the dissemination of HIV prevention research findings. Changes in treatment beliefs coincide with increased rates of condomless anal intercourse. Increased beliefs that treatments prevent HIV and increased condomless anal sex were observed for both HIV positive men and men who had not tested HIV positive. Results illustrate the emergence of an era where ART is the focus of HIV prevention and community-held beliefs and behaviors regarding definitions of risk create a new and potentially problematic environment for HIV transmission.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Alaei, K., Paynter, C. A., Juan, S. C., & Alaei, A. (2016). Using PrEP, losing condoms? PrEP promotion may undermine safe sex. AIDS, 30, 2753–2756.
Amico, R., McMahan, V., Goicochea, P., Vargas, L., Marcus, J. L., Grant, R. M., & Liu, A. (2012). Supporting study product use and accuracy in self-report in the iPrEx study: Next step counseling and neutral assessment. AIDS and Behavior, 16(5), 1243–1259.
Bavinton, B. R., Holt, M., Grulich, A. E., Brown, G., Zablotska, I. B., & Prestage, G. P. (2016). Willingness to act upon beliefs about ‘Treatment as Prevention’ among Australian gay and bisexual men. PLoS ONE, 11(1), e0145847. doi:10.1371/journal.pone.0145847.
Catania, J. A., Gibson, D., Chitwood, D., & Coates, T. J. (1990). Methodological problems in AIDS behavioral research: Influences on measurement error and participation bias in studies of sexual behavior. Psychological Bulletin, 108, 339–362.
Centers for Disease Control and Prevention. (2003). Advancing HIV prevention: New strategies for a changing epidemic: United States. Morbidity and Mortality Weekly Report, 52(15), 329–332.
Chen, Y. (2013). Treatment-related optimistic beliefs and risk of HIV transmission: A review of recent findings (2009-2012) in an era of treatment as prevention. Current HIV/AIDS Reports, 10(1), 79–88.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., & Fleming, T. R. (2011). Prevention of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine, 365(6), 493–505.
Cohen, M. S., McCauley, M., & Gamble, T. R. (2012). HIV treatment as prevention and HPTN 052. Current Opinion in HIV AIDS, 7(2), 99–105.
Crepaz, N., Hart, T., & Marks, G. (2004). Highly active antiretroviral therapy and high risk sexual behavior: A meta-analytic review. Journal of the American Medical Association, 292, 224–236.
Fellows, I. E., Morris, M., Birnbaum, J. K., Dombrowski, J. C., Buskin, S., Bennett, A., & Golden, M. R. (2015). Correction: A new method for estimating the number of undiagnosed HIV infected based on HIV testing history, with an application to men who have sex with men in Seattle/King County, WA. PLoS ONE, 10(8), e0135878. doi:10.1371/journal.pone.0135878.
Forsyth, A. D., & Valdiserri, R. O. (2012). Reaping the prevention benefits of highly active antiretroviral treatment: Policy implications of HIV Prevention Trials Network 052. Current Opinions in HIV AIDS, 7(2), 111–116.
Galletly, C. L., Pinkerton, S. D., & Petroll, A. E. (2008). CDC recommendations for opt-out testing and reactions to unanticipated HIV diagnoses. AIDS Patient Care STDS, 22(3), 189–193.
Hanif, H., Bastos, F. I., Malta, M., Bertoni, N., Winch, P. J., & Kerrigan, D. (2014). Where does treatment optimism fit in? Examining factors associated with consistent condom use among people receiving antiretroviral treatment in Rio de Janeiro, Brazil. AIDS and Behavior, 18(10), 1945–1954.
Harel, O., Pellowski, J., & Kalichman, S. (2012). Are we missing the importance of missing values in HIV prevention randomized clinical trials? Review and recommendations. AIDS and Behavior, 16(6), 1382–1393.
Holt, M., Lea, T., Murphy, D. A., Ellard, J., Rosengarten, M., Kippax, S. C., & De Wit, J. B. (2014). Australian gay and bisexual men’s attitudes to HIV treatment as prevention in repeated, national surveys, 2011–2013. PLoS ONE, 9(11), e112349. doi:10.1371/journal.pone.0112349.
Holt, M., Lea, T., Schmidt, H. M., Murphy, D., Rosengarten, M., Crawford, D., et al. (2016). Increasing belief in the effectiveness of HIV treatment as prevention: Results of repeated, national surveys of Australian gay and bisexual men, 2013–2015. AIDS and Behavior, 20, 1564–1571.
Holtgrave, D. R., Maulsby, C., Wehrmeyer, L., & Hall, H. I. (2012). Behavioral factors in assessing impact of HIV treatment as prevention. AIDS and Behavior, 16, 1085–1091.
Iwuji, C., Orne-Gliemann, J., Balestre, E., Larmarange, J., Thiebaut, R., Tanser, F., et al. (2016). The impact of universal test and treat on HIV incidence in a rural South African population: ANRS 12249 TasP trial, 2012–2016. Paper presented at the International AIDS Conference, Durban.
Jansen, K., Schmidt, A. J., Drewes, J., Bremer, V., & Marcus, U. (2016). Increased incidence of syphilis in men who have sex with men and risk management strategies, Germany, 2015. European Surveilance. doi:10.2807/1560-7917.ES.2016.21.43.30382.
Kalichman, S. C. (2008). Co-occurrence of treatment non-adherence and continued HIV transmission risk behaviors: Implications for positive prevention interventions. Psychosomatic Medicine, 70, 593–597.
Kalichman, S. C., DiBerto, G., & Eaton, L. (2008). HIV viral load in blood plasma and semen: Review and implications of empirical findings. Sexually Transmitted Diseases, 35, 55–60.
Kalichman, S. C., Eaton, L., Cain, D., Cherry, C., Fuhrel, A., Kaufman, M., & Pope, H. (2007a). Changes in HIV treatment beliefs and sexual risk behaviors among gay and bisexual men, 1997–2005. Health Psychology, 26(5), 650–656.
Kalichman, S. C., Eaton, L., & Cherry, C. (2010). Sexually transmitted infections and infectiousness beliefs among people living with HIV/AIDS: implications for HIV treatment as prevention. HIV Medicine, 11(8), 502–509.
Kalichman, S. C., Eaton, L., White, D., Cherry, C., Pope, H., Cain, D., & Kalichman, M. O. (2007b). Beliefs about treatments for HIV/AIDS and sexual risk behaviors among men who have sex with men, 1997–2006. Journal of Behavioral Medicine, 30(6), 497–503.
Kalichman, S. C., Nachimson, D., Cherry, C., & Williams, E. (1998). AIDS treatment advances and behavioral prevention setbacks: Preliminary assessment of reduced perceived threat of HIV-AIDS. Health Psychology, 17(6), 546–550.
Katz, D. A., Dombrowski, J. C., Bell, T. R., Kerani, R. P., & Golden, M. R. (2016). HIV incidence among men who have sex with men after diagnosis with sexually transmitted infections. Sexually Transmitted Disease, 43(4), 249–254.
Laga, M., & Piot, P. (2012). Prevention of sexual transmission of HIV: Real results, science progressing, societies remaining behind. AIDS, 26(10), 1223–1229.
Matthews, D. D., Herrick, A. L., Coulter, R. W., Friedman, M. R., Mills, T. C., Eaton, L. A., et al. (2016). Running backwards: Consequences of current HIV incidence rates for the next generation of Black MSM in the United States. AIDS and Behavior, 20(1), 7–16.
Mimiaga, M. J., Mayer, K. H., Reisner, S. L., Gonzalez, A., Dumas, B., Vanderwarker, R., et al. (2008). Asymptomatic gonorrhea and chlamydial infections detected by nucleic acid amplification tests among Boston area men who have sex with men. Sexually Transmitted Diseases, 35(5), 495–498.
Newman, C. E., de Wit, J., Persson, A., Holt, M., Slavin, S., Kidd, M. R., & Mao, L. (2015). Understanding concerns about treatment-as-prevention among people with HIV who are not using antiretroviral therapy. AIDS and Behavior, 19(5), 821–831.
Oldenburg, C. E., Barnighausen, T., Tanser, F., Iwuji, C. C., De Gruttola, V., Seage, G. R., et al. (2016). Antiretroviral therapy to prevent HIV acquisition in serodiscordant couples in a hyperendemic community in rural South Africa. Clinical Infectious Diseases, 63(4), 548–554.
Pantalone, D. W., Tomassilli, J. C., Starks, T. J., Golub, S. A., & Parsons, J. T. (2015). Unprotected anal intercourse with casual male partners in urban gay, bisexual, and other men who have sex with men. American Journal of Public Health, 105(1), 103–110.
Park, A. (2014). The end of AIDS. Time Magazine. http://time.com/3596979/the-end-of-aids/.
Payne, L., Lawrence, D., Soni, S., Llewellyn, C., & Dean, G. (2016). Investigating factors for increased gonorrhoea re-infection in men who have sex with men attending a genitourinary clinic: A qualitative study. International Journal of STD and AIDS. doi:10.1177/0956462416677916.
Pilcher, C. D., Eaton, L., Kalichman, S., Bisol, C., & de Souza Rda, S. (2006). Approaching “HIV elimination”: Interventions for acute HIV infection. Current HIV/AIDS Reports, 3(4), 160–168.
Risher, K., Mayer, K. H., & Beyrer, C. (2015). HIV treatment cascade in MSM, people who inject drugs, and sex workers. Current Opinion in HIV AIDS, 10(6), 420–429.
Schroder, K., Carey, M. P., & Vanable, P. (2003). Methodological challenges in research on sexual risk behavior: I Item content, scaling, and data analytic options. Annals of Behavioral Medicine, 26, 104–123.
Schwartlander, B., Stover, J., Hallett, T., Atun, R., Avila, C., Gouws, E., & Padian, N. (2011). Towards an improved investment approach for an effective response to HIV/AIDS. Lancet, 377(9782), 2031–2041.
Sood, N., Wagner, Z., Jaycocks, A., Drabo, E., & Vardavas, R. (2013). Test-and-treat in Los Angeles: A mathematical model of the effects of test-and-treat for the population of men who have sex with men in Los Angeles County. Clinical Infectious Diseases, 56(12), 1789–1796.
Tanser, F., Barnighausen, T., Grapsa, E., Zaidi, J., & Newell, M. L. (2013). High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science, 339(6122), 966–971.
Wilson, D. P. (2012). HIV treatment as prevention: Natural experiments highlight limits of antiretroviral treatment as HIV prevention. PLoS Medicine, 9(7), e1001231. doi:10.1371/journal.pmed.100123.
This study was funded by the National Institute on Drug Abuse Grant R01-DA033067 and a training grant from the National Institute of Mental Health T32-MH074387.
Conflict of Interest
Seth Kalichman has received research grants from the National Institutes of Health and a training grant from the National Institute of Mental Health. Devon Price declares that she has no conflict of interest. Lisa A. Eaton has received research grants from the National Institutes of Health and a training grant from the National Institute of Mental Health. Kaylee Burnham, Matthew Sullivan, Stephanie Finneran, Talea Cornelius and Aerielle Allen declare that she/he has no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all participants included in this study.
About this article
Cite this article
Kalichman, S.C., Price, D., Eaton, L.A. et al. Diminishing Perceived Threat of AIDS and Increasing Sexual Risks of HIV Among Men Who Have Sex with Men, 1997–2015. Arch Sex Behav 46, 895–902 (2017). https://doi.org/10.1007/s10508-016-0934-9
- HIV prevention
- HIV treatment
- Antiretroviral therapies (ART)
- Sexual behavior